Recruiting

A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(23 sites)

Brazil

Novartis Investigative Site, Manaus, Amazonas

Novartis Investigative Site, Brasília, Federal District

Novartis Investigative Site, Rio de Janeiro, Rio de Janeiro

Novartis Investigative Site, Sorocaba, São Paulo

Novartis Investigative Site, Sao Jose Rio Preto

Colombia

Novartis Investigative Site, Barranquilla, Atlántico

Novartis Investigative Site, Bucaramanga, Santander Department

Novartis Investigative Site, Cali, Valle del Cauca Department

India

Novartis Investigative Site, Belagavi, Karnataka

Novartis Investigative Site, Mumbai, Maharashtra

Novartis Investigative Site, Pune, Maharashtra

Novartis Investigative Site, Jaipur, Rajasthan

Novartis Investigative Site, Chennai, Tamil Nadu

Malaysia

Novartis Investigative Site, Kuantan, Pahang

Novartis Investigative Site, Ipoh, Perak

Novartis Investigative Site, Seberang Jaya, Pulau Pinang

Novartis Investigative Site, Miri, Sarawak

Novartis Investigative Site, Kuala Selangor

Singapore

Novartis Investigative Site, Singapore

Vietnam

Novartis Investigative Site, Haiphong

Novartis Investigative Site, Hanoi

Novartis Investigative Site, Ho Chi Minh City